GSK launches £2bn buyback on strong HIV and cancer drugs sales
- Posted on February 5, 2025
- By Financial Times
- 5 Views
GSK launches £2bn buyback on strong HIV and cancer drugs sales
UK pharma group raises long-term annual sales forecast to over £40bn by 2031
